A new percutaneous technique: N-butyl cyanoacrylate adhesive for the treatment of giant saphenous vein insufficiency

Abstract

Background

We have made a retrospective evaluation of the results of the cyanoacrylate ablation technique which has recently started to be used in the treatment of giant saphenous vein insufficiency today and in which tumescent anesthesia is not required.

Methods

Giant saphenous vein was treated in 50 patients between September 2015 and September 2016 by using endovenous cyanoacrylate ablation. In the procedure, tumescent anesthesia and varsity socks were not used. Control duplex ultrasound evaluation was performed in the post-procedural 1st, 6th and 12th months. Venous Clinical Severity Score and Aberdeen Varicose Vein Questionnaire scores were evaluated.

Results

In the 50 patients who were treated, full closure was observed in giant saphenous vein in 47 (94%) patients in the 12th month control duplex ultrasound. The mean age of the patients was 46.4 (20–70) and 30 (60%) of them were female. The median Venous Clinical Severity Score scores in the 1st, 6th and 12th months were 3, 2 and 1, respectively (p < 0.001); the median Aberdeen Varicose Vein Questionnaire scores in the 1st, 6th and 12th months were 7, 5 and 4, respectively (p < 0.001). In the access site, two (4%) patients developed phlebitis and one (2%) developed ecchymosis. However, deep venous thrombosis, pulmonary embolism and paresthesia were not observed.

Conclusion

Considering the early period results in the treatment of giant saphenous vein insufficiency, cyanoacrylate ablation makes a more reliable alternative than endovenous thermal ablation methods in that it does not require tumescent anesthesia and it has a low incidence of adverse effects.

Keywords

Cyanoacrylate endovenous saphenous ablation

Get full access to this article

View all access options for this article.

References

Pannier

F and

Rabe

Progression in venous pathology. Phlebology 2015; 30: 95–97.

Mc Lafferty

Passman

Caprini

et al.

Increasing awareness about venous disease: the American Venous Forum expands the National Venous Screening Program. J Vasc Surg 2008; 48: 394–399.

Brand

Dannenberg

Abbott

et al.

The epidemiology of varicose veins: the Framingham Study. Am J Prev Med 1988; 4: 96–101.

Gloviczki

Comerato

Dalsing

et al.

The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.

J Vasc Surg 2011; 53: 2S–48S.

Almeida

Kaufman

Göckeritz

et al.

Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study(RECOVERY study). J Vasc Radiol 2009; 20: 752–759.

Brittenden

Cotton

Elders

et al.

A randomized trial comparing treatments for varicose veins. N Engl J Med 2014; 371: 1218–1227.

Guex

J-J

Allaert

F-A

Gillet

J-L

et al.

İmmediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12.173 sclerotherapy sessions. Dermatol Surg 2005; 31: 123–128; discussion 128

RWL

Pilotelle

Paraskevas

et al.

Three cases of stroke following peripheral venous interventions. Phlebology 2011; 26: 280–284.

Labenz

J and

Börsch

Bleeding gastric and duodenal varicose veins: endoscopic embolisation using tissue adhesives. Dtsch Med Wochenschr 1992; 117: 1274–1277.

10.

Linfante

I and

Wakhloo

AK.

Brain aneurysms and arteriovenous malformations: advancements and emerging treatments in endovascular embolization. Stroke 2007; 38: 1411–1417.

11.

Brothers

Kaufmann

Fox

et al.

N-butyl 2-cyanoacrylate substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. Am J Neuroradiol 1989; 10: 777–786.

12.

National Institute for Health and Care Excellence. Varicose veins in the legs. The diagnosis and management of varicose veins. UK: National Institute for Health and Care Excellence, www.nice.org.uk/guidance/cg168 (2013, accessed 25 July 2017).

13.

Almeida

Javier

Mackay

et al.

Two-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. Phlebology 2015; 30: 397–404.

14.

Proebstle

Status of cyanoacrylate glue for saphenous ablation. In: The 10th international vein congress, Miami, Florida, USA, 31 May–3 June 2012.

15.

Tok

Tuydes

Yuksel

et al.

Early-term outcomes for treatment of saphenous vein insufficiency with N-butyl cyanoacrylate: a novel, non-thermal, and non-tumescent percutaneous embolization technique. Heart Surg Forum 2016; 19: E118–E22.

16.

Morrison

Gibson

McEnroe

et al.

Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins(VeClose). J Vasc Surg 2015; 61: 985–994.

17.

Gibson

and Ferris

Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular 2017; 25: 149–156.